Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug2ways: Reasoning over causal paths in biological networks for drug discovery
Daniel Rivas-Barragan, Sarah Mubeen, Francesc Guim Bernat, et al.
PLoS Computational Biology (2020) Vol. 16, Iss. 12, pp. e1008464-e1008464
Open Access | Times Cited: 24

Showing 24 citing articles:

Patient-specific Boolean models of signalling networks guide personalised treatments
Arnau Montagud, Jonas Béal, Luis Tobalina, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 74
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice
Paolo Fusar‐Poli, Mirko Manchia, Nikolaos Koutsouleris, et al.
European Neuropsychopharmacology (2022) Vol. 63, pp. 17-34
Open Access | Times Cited: 65
Cross-dataset reproducibility of human retinotopic maps
Marc M. Himmelberg, Jan W. Kurzawski, Noah C. Benson, et al.
NeuroImage (2021) Vol. 244, pp. 118609-118609
Open Access | Times Cited: 57
Individualized cognitive neuroscience needs 7T: Comparing numerosity maps at 3T and 7T MRI
Yuxuan Cai, Shir Hofstetter, Wietske van der Zwaag, et al.
NeuroImage (2021) Vol. 237, pp. 118184-118184
Open Access | Times Cited: 35
Machine Learning for Causal Inference in Biological Networks: Perspectives of This Challenge
Paola Lecca
Frontiers in Bioinformatics (2021) Vol. 1
Open Access | Times Cited: 33
Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises
Natesh Singh, Bruno O. Villoutreix
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2537-2548
Open Access | Times Cited: 28
Comprehensive applications of the artificial intelligence technology in new drug research and development
Hongyu Chen, Dong Xin Lu, Ziyi Xiao, et al.
Health Information Science and Systems (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 4
Considerations and challenges for sex-aware drug repurposing
Jennifer L. Fisher, Emma F. Jones, Victoria L. Flanary, et al.
Biology of Sex Differences (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Computational modeling approaches and regulatory pathways for drug combinations
Lucas Fillinger, Sebastian G. Walter, Matthias Ley, et al.
Drug Discovery Today (2025), pp. 104345-104345
Open Access
A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods
Yinghong Li, Yinqi Yang, Zhuohao Tong, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 3
Task-driven knowledge graph filtering improves prioritizing drugs for repurposing
Florin Ratajczak, Mitchell Joblin, Martin Ringsquandl, et al.
BMC Bioinformatics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Ensembles of knowledge graph embedding models improve predictions for drug discovery
Daniel Rivas-Barragan, Daniel Domingo‐Fernándéz, Yojana Gadiya, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 11
Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery
Daniel Domingo‐Fernándéz, Yojana Gadiya, Abhishek Patel, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 2, pp. e1009909-e1009909
Open Access | Times Cited: 10
Translational Informatics for Natural Products as Antidepressant Agents
Rajeev K. Singla, Shikha Joon, Li Shen, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 6
Open Biomedical Network Benchmark A Python Toolkit for Benchmarking Datasets with Biomedical Networks
Renming Liu, Arjun Krishnan
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Time-stage driven pathfinding framework for optimized medical treatments
Karen Gishyan, Hasmik Sahakyan, Levon Aslanyan
Cogent Engineering (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Towards a global investigation of transcriptomic signatures through co-expression networks and pathway knowledge for the identification of disease mechanisms
Rebeca Queiroz Figueiredo, Tamara Raschka, Alpha Tom Kodamullil, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 14, pp. 7939-7953
Open Access | Times Cited: 5
Patient-specific Boolean models of signaling networks guide personalized treatments
Arnau Montagud, Jonas Béal, Luis Tobalina, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
Belinda B. Garana, James H. Joly, Alireza Delfarah, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 1
IN SILICO PREDICTION OF POTENTIAL DERMATOLOGICAL EFFECTS OF A SYNTHETIC ANTIOXIDANT
O. Ye. Baliuk, Elena Vazhnichaya
Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії (2024) Vol. 24, Iss. 2, pp. 108-112
Open Access
Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
Belinda B. Garana, James H. Joly, Alireza Delfarah, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Refinement of Biological Regulatory Graphs using Functional Enrichment
Jeffrey Page, Matthew C. Morris, Gary R. Skuse, et al.
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) (2022), pp. 3580-3586
Closed Access
Towards a global investigation of transcriptomic signatures through co-expression networks and pathway knowledge for the identification of disease mechanisms
Rebeca Queiroz Figueiredo, Tamara Raschka, Alpha Tom Kodamullil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery
Daniel Domingo‐Fernándéz, Yojana Gadiya, Abhishek Patel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top